LECNAC

Synthetic lectins for beta-GlcNAc: evaluation of their potential biological applications towards O-GlcNAc-modified proteins

Coordinatore	UNIVERSITY OF BRISTOL    more  Organization address address: TYNDALL AVENUE SENATE HOUSE city: BRISTOL postcode: BS8 1TH contact info Titolo: Ms. Nome: Johanna Cognome: Rule Email: send email Telefono: -9288769 Fax: -9250973
Nazionalità Coordinatore	United Kingdom [UK]
Totale costo	181˙103 €
EC contributo	181˙103 €
Programma	FP7-PEOPLE Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Code Call	FP7-PEOPLE-2009-IEF
Funding Scheme	MC-IEF
Anno di inizio	2010
Periodo (anno-mese-giorno)	2010-05-01   -   2012-04-30

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	UNIVERSITY OF BRISTOL  Organization address address: TYNDALL AVENUE SENATE HOUSE city: BRISTOL postcode: BS8 1TH contact info Titolo: Ms. Nome: Johanna Cognome: Rule Email: send email Telefono: -9288769 Fax: -9250973	UK (BRISTOL)	coordinator	181˙103.20

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'Lectins are carbohydrate-binding proteins which play many roles in nature, and are important also as tools for biological research. For example, they are used to make fluorescent reagents which bind to, and thus identify, particular carbohydrate units, and also to make separation media which distinguish between differently glycosylated biomolecules. An important target for such reagents/media is beta-GlcNAc on serine or threonine (the O-GlcNAc protein modification). This moiety has been implicated in many biological processes and human diseases such as diabetes and neurobiological disorders. The lectins used to bind O-GlcNAc do not perform especially well, and the host group have shown that, remarkably, a designed “synthetic lectin” may be superior. The aim of the project is to explore this possibility, developing and testing biological tools (e.g. stains and separation media) based on the synthetic system. The research will involve international collaboration with five laboratories, two in Europe (Madrid and Leuven) and three in the US. The applicant will move from Spain to Bristol (UK) to carry out this research, while undergoing training in a variety of scientific and complementary skills (including during visits to two collaborating laboratories). The applicant plans a scientific career at the interface between supramolecular chemistry and biology (biosupramolecular chemistry). The project will expand his synthetic, organic and supramolecular chemical knowledge, introduce him to certain biological techniques (e.g. Western blotting, affinity chromatography and biological NMR), and encourage him to develop his independent scientific ideas. At the end of the Fellowship he will be well-positioned to apply for independent positions in the ERA. If successful, his research will have shown that synthetic receptors can complement proteins in performing complex and difficult molecular recognition tasks.'